A rare case of nasopharyngeal adenoid cystic carcinoma treated with cetuximab-based induction therapy followed by concurrent chemoradiotherapy

Oral Oncol. 2019 Feb:89:161-163. doi: 10.1016/j.oraloncology.2018.12.022. Epub 2018 Dec 26.

Authors

Shihai Wu¹, Jingwen Liu², Rencui Quan², Ling Han³

Affiliations

¹ Department of Radiation Oncology, Second Clinical Medicine College of Jinan University, Shenzhen People's Hospital, China. Electronic address: Jiangxiwu84@126.com.
² Department of Radiation Oncology, Second Clinical Medicine College of Jinan University, Shenzhen People's Hospital, China.
³ Department of E.N.T, Second Clinical Medicine College of Jinan University, Shenzhen People's Hospital, China.

PMID: 30594461
DOI: 10.1016/j.oraloncology.2018.12.022

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Carcinoma, Adenoid Cystic / diagnosis*
Carcinoma, Adenoid Cystic / drug therapy*
Carcinoma, Adenoid Cystic / pathology
Cetuximab / pharmacology
Cetuximab / therapeutic use*
Chemoradiotherapy / methods*
Female
Humans
Nasopharyngeal Neoplasms / diagnosis*
Nasopharyngeal Neoplasms / drug therapy*
Nasopharyngeal Neoplasms / pathology

Substances

Cetuximab